Baltschieder, Switzerland

Anton Zenklusen


 

Average Co-Inventor Count = 2.3

ph-index = 1


Location History:

  • Balthschieder, CH (2014)
  • Baltschieder, CH (2012 - 2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Anton Zenklusen: Innovator in Cyanopyridine Production

Introduction: Anton Zenklusen, an accomplished inventor based in Baltschieder, Switzerland, has made significant contributions to the field of chemical production. With a total of four patents to his name, he has established himself as a key figure in the innovation of methods and devices used in the synthesis of cyanopyridines.

Latest Patents: Zenklusen's latest patents focus on the development of devices and methods for the production of cyanopyridines. His inventions provide a novel approach to creating this essential compound, wherein he outlines an innovative method alongside the design of the devices necessary for its realization, further expanding the possibilities in chemical manufacturing.

Career Highlights: Anton Zenklusen currently works at Lonza Inc., a company renowned for its contributions to the life sciences and pharmaceuticals sector. His role involves pushing the boundaries of chemical innovation, where he applies his expertise in cyanopyridine production to enhance productivity and efficiency in manufacturing processes.

Collaborations: Collaborating with notable colleagues such as Daniel Pianzola and Gesa Paradies, Zenklusen is part of a dynamic team that fosters creativity and advancement within the company. These partnerships are pivotal in driving forward innovative solutions in the field of chemical production.

Conclusion: Anton Zenklusen’s work exemplifies the spirit of innovation in the production of cyanopyridines. As a dedicated inventor at Lonza Inc., his patents contribute to the evolving landscape of chemical manufacturing, showcasing his commitment to advancing industry practices through his inventive methods and collaborative efforts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…